Robust association between vascular habitats and patient prognosis in glioblastoma: An international multicenter study
Por:
Alvarez-Torres M, Juan-Albarracin J, Fuster-Garcia E, Bellvis-Bataller F, Lorente D, Reynes G, de Mora J, Aparici-Robles F, Botella C, Munoz-Langa J, Faubel R, Asensio-Cuesta S, Garcia-Ferrando G, Chelebian E, Auger C, Pineda J, Rovira A, Oleaga L, Molla-Olmos E, Revert A, Tshibanda L, Crisi G, Emblem K, Martin D, Due-Tonnessen P, Meling T, Filice S, Saez C, Garcia-Gomez J
Ahead of Print:
1 oct 2019
Resumen:
Background Glioblastoma (GBM) is the most aggressive primary brain tumor, characterized by a heterogeneous and abnormal vascularity. Subtypes of vascular habitats within the tumor and edema can be distinguished: high angiogenic tumor (HAT), low angiogenic tumor (LAT), infiltrated peripheral edema (IPE), and vasogenic peripheral edema (VPE). Purpose To validate the association between hemodynamic markers from vascular habitats and overall survival (OS) in glioblastoma patients, considering the intercenter variability of acquisition protocols. Study Type Multicenter retrospective study. Population In all, 184 glioblastoma patients from seven European centers participating in the NCT03439332 clinical study. Field Strength/Sequence 1.5T (for 54 patients) or 3.0T (for 130 patients). Pregadolinium and postgadolinium-based contrast agent-enhanced T-1-weighted MRI, T-2- and FLAIR T-2-weighted, and dynamic susceptibility contrast (DSC) T-2* perfusion. Assessment We analyzed preoperative MRIs to establish the association between the maximum relative cerebral blood volume (rCBV(max)) at each habitat with OS. Moreover, the stratification capabilities of the markers to divide patients into "vascular" groups were tested. The variability in the markers between individual centers was also assessed. Statistical Tests Uniparametric Cox regression; Kaplan-Meier test; Mann-Whitney test. Results The rCBV(max) derived from the HAT, LAT, and IPE habitats were significantly associated with patient OS (P < 0.05; hazard ratio [HR]: 1.05, 1.11, 1.28, respectively). Moreover, these markers can stratify patients into "moderate-" and "high-vascular" groups (P < 0.05). The Mann-Whitney test did not find significant differences among most of the centers in markers (HAT: P = 0.02-0.685; LAT: P = 0.010-0.769; IPE: P = 0.093-0.939; VPE: P = 0.016-1.000). Data Conclusion The rCBV(max) calculated in HAT, LAT, and IPE habitats have been validated as clinically relevant prognostic biomarkers for glioblastoma patients in the pretreatment stage. This study demonstrates the robustness of the hemodynamic tissue signature (HTS) habitats to assess the GBM vascular heterogeneity and their association with patient prognosis independently of intercenter variability. Technical Efficacy Stage: 2 J. Magn. Reson. Imaging 2019.
Filiaciones:
Alvarez-Torres M:
Univ Politecn Valencia, BDSLab, Inst Univ Tecnol Informac & Comunicac ITACA, Valencia, Spain
Juan-Albarracin J:
Univ Politecn Valencia, BDSLab, Inst Univ Tecnol Informac & Comunicac ITACA, Valencia, Spain
Fuster-Garcia E:
Oslo Univ Hosp, Dept Diagnost Phys, Oslo, Norway
Bellvis-Bataller F:
Univ Politecn Valencia, BDSLab, Inst Univ Tecnol Informac & Comunicac ITACA, Valencia, Spain
Lorente D:
Hosp Prov Castellon, Dept Med Oncol, Castellon De La Plana, Castellon De La, Spain
Reynes G:
Hlth Res Inst Hosp La Fe, Canc Res Grp, Valencia, Spain
de Mora J:
Inst Invest Sanitaria La Fe, Lab Cellular & Mol Biol, Valencia, Spain
Aparici-Robles F:
Hosp Univ & Politecn La Fe, Area Clin Imagen Med, Valencia, Spain
Botella C:
Hosp Univ & Politecn La Fe, Area Clin Neurociencias, Valencia, Spain
Munoz-Langa J:
Hlth Res Inst Hosp La Fe, Canc Res Grp, Valencia, Spain
Faubel R:
Univ Valencia, Dept Fisioterapia, Valencia, Spain
Asensio-Cuesta S:
Univ Politecn Valencia, BDSLab, Inst Univ Tecnol Informac & Comunicac ITACA, Valencia, Spain
Garcia-Ferrando G:
Univ Politecn Valencia, BDSLab, Inst Univ Tecnol Informac & Comunicac ITACA, Valencia, Spain
Chelebian E:
Univ Autonoma Barcelona, Dept Radiol, Magnet Resonance Unit, Hosp Vall dHebron, Barcelona, Spain
Auger C:
Univ Autonoma Barcelona, Dept Radiol, Magnet Resonance Unit, Hosp Vall dHebron, Barcelona, Spain
Pineda J:
Hosp Clin Barcelona, Barcelona, Spain
Rovira A:
Univ Autonoma Barcelona, Dept Radiol, Magnet Resonance Unit, Hosp Vall dHebron, Barcelona, Spain
Oleaga L:
Hosp Clin Barcelona, Barcelona, Spain
Molla-Olmos E:
Hosp Univ Ribera, Dept Radiodiagnost, Valencia, Spain
Revert A:
Hosp Manises, Valencia, Spain
Tshibanda L:
Ctr Hosp Univ Liege, Serv Med Radiodiagnost, Liege, Belgium
Crisi G:
Azienda Osped Univ Parma, Neuroradiol, Parma, Italy
Emblem K:
Oslo Univ Hosp, Dept Diagnost Phys, Oslo, Norway
Martin D:
Ctr Hosp Univ Liege, Serv Neurochirurug, Liege, Belgium
Due-Tonnessen P:
Oslo Univ Hosp, Rikshosp, Dept Radiol, Oslo, Norway
Meling T:
Oslo Univ Hosp, Dept Neurosurg, Oslo, Norway
Geneva Univ Hosp, Dept Neurosurg, Geneva, Switzerland
Filice S:
Azienda Osped Univ Parma, Med Phys, Parma, Italy
Saez C:
Univ Politecn Valencia, BDSLab, Inst Univ Tecnol Informac & Comunicac ITACA, Valencia, Spain
Garcia-Gomez J:
Univ Politecn Valencia, BDSLab, Inst Univ Tecnol Informac & Comunicac ITACA, Valencia, Spain
|